Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS BILATERAL MODIFICATION DE-OBLIGATES CANCELING YEAR FUNDS FROM REQUISITION OS256610 IN THE AMOUNT OF (-$615,177.10) FROM CLIN0006 AND FROM REQUISITION OS257789 IN THE AMOUNT OF (-$222.20) FROM CLIN00001.
VENATORX PHARMACEUTICALS INC · Department of Health and Human Services
- Value
- $131,756,814
- Start
- Jul 17, 2019
- End
- Sep 30, 2025
- Action date
- May 26, 2026
- PIID
- 75A50119C00007
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- DOWNINGTOWN, PA
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS BILATERAL MODIFICATION DE-OBLIGATES CANCELING YEAR FUNDS FROM REQUISITION OS256610 IN THE AMOUNT OF (-$615,177.10) FROM CLIN0006 AND FROM REQUISITION OS257789 IN THE AMOUNT OF (-$222.20) FROM CLIN00001.
Need modifications, related awards, and vendor peers? Open the full award workspace.